Previous studies have supported the hypothesis of anti-neuroblastoma immune responses supported by in vitro assays of the inhibition of NB cells with lymphocytes obtained from NB patients and the association of the expression profiles of anti-inflammatory cytokines such as IL-10 and TGFβ1, with M2 polarized macrophage combination. This evidence concerns the gene TGFB1 and neuroblastoma.